25 - Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results from the Phase 2 VOYAGE Study
32 - Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn’s Disease Patients with Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results from the POWER Study
33 - Symptomatic Improvement Observed Within 2 Days of Etrasimod Induction Therapy: Results from ELEVATE UC 52 and ELEVATE UC 12 Studies in Patients with Ulcerative Colitis
34 - Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results from the Phase 3 QUASAR Induction Study
35 - Risankizumab Induction Therapy in Patients WIth Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
39 - Plant-Based Meals Generate Lower Ammonia and Have a Unique Metabolomic Signature Compared to Meat-Based Meals Despite Similar Baseline Microbiome in Patients with Cirrhosis: A Randomized Clinical Trial
48 - Implementation of a Digital Cancer Risk Assessment Tool and Genetic Testing Program in Gastroenterology Practices Throughout the US Identifies Inherited Cancer Susceptibility Syndromes in 15.6% of Patients Tested
49 - Sessile Serrated Lesion Detection Rate in Individuals with Positive Fecal Immunohistochemical Test Undergoing Colonoscopy: Results from a Large Nationwide Veterans Affairs Database
50 - Use of Mechanical Enhanced Colonoscopy to Improve Polyp Detection During Colorectal Cancer Screening: A Preliminary Results of Real-World Healthcare Database Analysis
51 - Lower Incidence of Gastrointestinal Cancers in Sodium Glucose Co-Transporter-2 Inhibitor-Treated Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study in the United States
52 - Interventions to Improve the Quality of Screening-Related Colonoscopy: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
54 - Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening: A Prospective Clinical Validation Study (BLUE-C) (Late-Breaking Abstract)
Location: Ballroom B
Late Breaking Abstract Presenter: Thomas F. Imperiale, MD – Indiana University Medical Center
Oral Paper PresentationAnnual Scientific Meeting
3:45 PM - 4:30 PM PT
Break - Visit Exhibit Hall and Browse Scientific Posters
3:45 PM - 4:30 PM PT
Break - Visit Exhibit Hall and Browse Scientific Posters